Morning Overview on MSN
New combination therapy achieves unprecedented remission in glioblastoma brain cancer models
Glioblastoma is the most aggressive primary brain cancer in adults, killing most patients within two years of diagnosis ...
Mortality disparities among people of different genetic ancestries are increasing, highlighting the need for more diverse ...
At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...
Lung cancer remains the leading cause of cancer-related mortality worldwide, underscoring the urgent need for improved therapeutic strategies grounded in ...
Researchers at VIB and VUB have developed a powerful new way to study how the immune system behaves inside lung tumors. By combining a patient-relevant mouse model with single-cell technologies, the ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Earlier computational models helped scientists categorize ...
With more accessible AI models shifting the landscape of cancer research and treatments, scientists weigh in on whether AI ...
Morning Overview on MSN
Study links extra chromosome sets to tumor spread and cell mobility
Cancer cells that accumulate extra copies of their entire chromosome set can start behaving like immune cells, swallowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results